coBRIM: a phase 3, double-blind, placebo-controlled study of vemurafenib versus vemurafenib + cobimetinib in previously untreated BRAFV600 mutation–positive patients with unresectable locally advanced or metastatic melanoma (NCT01689519)
| Image |  |
|---|---|
| Description | article published in 2015 |
| Author/s |
author: Grant McArthur James Larkin Daniil Stroyakovskiy Paolo Antonio Ascierto Antoni Ribas Michele Maio |
| Publication date | 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |